GlobalData on MSN13d
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancer
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
The Financial Express10d
New mRNA vaccine against tuberculosis effectively boosts immunity, study reveals
Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...
Cancer Therapy Advisor12d
FDA Allows Use of Recombinant BCG Through Expanded Access Program
The FDA has authorized an expanded access program that will allow for the use of a recombinant bacillus Calmette-Guerin product.
FierceBiotech13d
IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock
UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an early-phase oncolytic virus that could work like a turbocharged Bacillus Calmette ...
emjreviews.com8d
New mRNA Vaccine Boosts TB Protection
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
Hosted on MSN14d
Leprosy outbreak in Negeri Sembilan: Here’s everything you need to know about the disease
Leprosy has caused one death in Kuala Pilah, Negeri Sembilan as of February 2025. Leprosy is not highly contagious ...
Renal & Urology News15d
Nadofaragene Firadenovec for BCG-Unresponsive NMIBC Shows Real-World Benefit
Nadofaragene firadenovec appears effective in real-world patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer ...